Current Perspectives on Antifungal Resistance: Focus on Opportunistic Mycoses
DOI:
https://doi.org/10.56294/saludcyt20241064Keywords:
Opportunistic Mycosis, Antifungal Resistance, Antifungals, Resistance GenesAbstract
Introduction: opportunistic mycoses, caused by fungi in individuals with compromised immune systems, are on the rise, posing significant challenges in healthcare. This article reviews antifungal resistance with the aim of highlighting its increasing incidence and the need for new therapeutic strategies and precise diagnostic methods. The necessity for standardized laboratory protocols and the implementation of sensitive techniques for early detection and optimal treatment is emphasized.
Methods: a systematic review was conducted using PubMed, Scopus, and Google Scholar; search terms and Boolean operators such as "(Opportunistic Mycoses) AND (Antifungal Resistance)" and "(Antifungals) AND (Resistance Genes)" were used. Additionally, the guidelines established by the PRISMA statement were followed, and the PICO approach was employed.
Results: twelve studies were evaluated; 58,33 % (n=7) assessed antifungal resistance, while 41,67 % (n=5) addressed aspects such as mechanisms of action and genetics. 66 % of the studies evaluated resistance in Candida spp., while 16,7 % analyzed resistance in Aspergillus spp., making them the most studied pathogens. Various resistance genes were evaluated in all studies; moreover, fluconazole was found to be the most studied antifungal, followed by amphotericin B and voriconazole.
Conclusion: early identification of antifungal resistance, the development of new therapies, and the standardization of diagnostic methods are essential to mitigate its impact on public health
References
1. Wiederhold NP. Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance. Clin Chem. 2021;68(1):83–90.
2. Kuchi Bhotla H, Balasubramanian B, Meyyazhagan A, Pushparaj K, Easwaran M, Pappusamy M, et al. Opportunistic mycoses in COVID-19 patients/survivors: Epidemic inside a pandemic. J Infect Public Health. 2021;14(11):1720–6.
3. Kean R, Ramage G. Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris. mSphere. 2019;4(4).
4. Rogers TR, Verweij PE, Castanheira M, Dannaoui E, White PL, Arendrup MC, et al. Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications. Journal of Antimicrobial Chemotherapy. 2022;77(8):2053–73.
5. Ivanov M, Ćirić A, Stojković D. Emerging Antifungal Targets and Strategies. Int J Mol Sci. 2022;23(5):2756.
6. Qin Y, Wang J, Lv Q, Han B. Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review. Antimicrob Agents Chemother. 2023;67(6).
7. Bazira J, Nalumaga P, Tuhamize B, Orishaba F, Frederickson W, Taseera K. Antifungal Susceptibility of Pathogenic Moulds isolated from patients at Tertiary Hospital in South western Uganda. 2023.
8. Miruka H, Omwenga E, Stanslaus M, Silas A. Incidence, antifungal resistance properties, and virulence traits of Candida species isolated from HIV/AIDS Patients from the hospital system in Kenya. 2022.
9. Zaragoza O, Alcázar L, Trevijano N. Global emergence of resistance to fluconazole and voriconazole in Candida parapsilosis in tertiary hospitals in Spain during the COVID-19 pandemic. MedRxiv. 2022.
10. Rasouli S, Shankarnarayan S, Galon C, Charlebois DA. Identification and Elimination of Antifungal Tolerance in Candida auris. bioRxiv. 2022.
11. Valero C, Mcmanus M, Ashvatti A, Tindale J, Gago S, Bromley M. Reversing olorofim activity reveals multifactorial drug tolerance in Aspergillus fumigatus. bioRxiv. 2023.
12. Arastehfar A, Daneshnia F, Hovhannisyan H, Cabrera N, Ilkit M, Desai J, et al. A multidimensional assessment of in-host fitness costs of drug resistance in the opportunistic fungal pathogen Candida glabrata. bioRxiv. 2023.
13. Wang X, Yusufu A, Hasimu H, Abliz P. Whole genome sequencing of newly emerged fungal pathogen Aspergillus lentulus and its Azole resistance gene prediction. bioRxiv. 2023.
14. Chang Z, Billmyre RB, Chan Lee S, Heitman J. Broad antifungal resistance mediated by RNAi-dependent epimutation in the basal human fungal pathogen Mucor circinelloides. bioRxiv. 2019.
15. Kannan A, Asner SA, Trachsel E, Kelly S, Parker J, Sanglard D. Comparative genomics for the elucidation of multidrug resistance (MDR) in Candida lusitaniae. bioRxiv. 2019.
16. Luan Q, Zou P, Liu J, Li P. RETRACTED: Antifungal activity, synergism with fluconazole or amphotericin B and potential mechanism of direct current against Candida albicans biofilms and persisters. Res Sq. 2023.
17. Carolus H, Sofras D, Boccarella G, Sephton-Clark P, Lobo Romero C, Vergauwen R, et al. Acquired amphotericin B resistance and fitness trade-off compensation in Candida auris. Res Sq. 2023.
18. Qadri H, Haseeb Shah A, Ahmad Mir M, Fazal Qureshi M, Prasad R. Quinidine drug resistance transporter knockout Candida cells modulate glucose transporter expression and accumulate metabolites leading to enhanced azole drug resistance. Fungal Genetics and Biology. 2022.
19. Bhabhor U, Mistry Y, Mullan S. Evaluation of Sensitivity and Specificity of Direct Microscopical Examination of Suspected Mucor Mycosis Samples by Potassium Hydroxide (KOH) during Covid-19 Pandemic Era. Adv Infect Dis. 2022;12(04):776–80.
20. Dass SM, Vinayaraj E V., Pavavni K, Pallam A, Rao MS. Comparison of KOH, Calcofluor White and Fungal Culture for Diagnosing Fungal Onychomycosis in an Urban Teaching Hospital, Hyderabad. Indian Journal of Microbiology Research. 2015;2(3):148.
21. Park HJ, Kim JH, Ryu JW. Differences in the accuracy of potato dextrose agar and CHROMagar media in diagnosing oral candidiasis. Oral Biology Research. 2021;45(3):119–24.
22. Nadeem SG, Hakim ST, Kazmi SU. Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings. Libyan Journal of Medicine. 2010;5(1):2144.
23. de Jong AW, Dieleman C, Carbia M, Mohd Tap R, Hagen F. Performance of Two Novel Chromogenic Media for the Identification of Multidrug-Resistant Candida auris Compared with Other Commercially Available Formulations. J Clin Microbiol. 2021;59(4).
24. Das S, Sharma S, Kar S, Sahu S, Samal B, Mallick A. Is inclusion of Sabouraud dextrose agar essential for the laboratory diagnosis of fungal keratitis? Indian J Ophthalmol. 2010;58(4):281.
25. Das S, Singh S, Tawde Y, Chakrabarti A, Rudramurthy SM, Kaur H, et al. A Selective Medium for Isolation and Detection of Candida auris, an Emerging Pathogen. J Clin Microbiol. 2021;59(2).
26. Sheppard DC, Locas MC, Restieri C, Laverdiere M. Utility of the Germ Tube Test for Direct Identification of Candida albicans from Positive Blood Culture Bottles. J Clin Microbiol. 2008;46(10):3508–9.
27. Shields RK, Nguyen MH, Press EG, Updike CL, Clancy CJ. Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure. Antimicrob Agents Chemother. 2013;57(8):3528–35.
28. Ruiz de Alegría Puig C, Agüero-Balbín J, Fernández-Mazarrasa C, Martínez-Martínez L. Evaluation of the Vitek-MSTM system in the identification of Candida isolates from bloodstream infections. Rev Iberoam Micol. 2018;35(3):130–3.
29. Garcia-Effron G. Molecular Markers of Antifungal Resistance: Potential Uses in Routine Practice and Future Perspectives. Journal of Fungi. 2021;7(3):197.
30. Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther. 2009;7(10):1201–21.
31. Long N, Liu J, Liu J, Li Y, Hou Y, Liao X, et al. Single-Molecule Real-Time Sequencing to Explore the Mycobiome Diversity in Malt. Microbiol Spectr. 2022;10(5).
32. Tse OYO, Jiang P, Cheng SH, Peng W, Shang H, Wong J, et al. Genome-wide detection of cytosine methylation by single molecule real-time sequencing. Proceedings of the National Academy of Sciences. 2021;118(5).
33. Schelenz S, Barnes RA, Barton RC, Cleverley JR, Lucas SB, Kibbler CC, et al. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis. 2015;15(4):461–74.
34. Vitiello A, Ferrara F, Boccellino M, Ponzo A, Cimmino C, Comberiati E, et al. Antifungal Drug Resistance: An Emergent Health Threat. Biomedicines. 2023;11(4):1063.
35. Berkow E, Lockhart S. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017; Volume 10:237–45.
36. Lotfali E, Ghajari A, Kordbacheh P, Zaini F, Mirhendi H, Mohammadi R, et al. Regulation of ERG3, ERG6, and ERG11 Genes in Antifungal-Resistant isolates of Candida parapsilosis. Iran Biomed J. 2017;21(4):275–81.
37. Navarro MI, Pérez C, Parker J, Kelly S, Heitman J. Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the Mucor species complex. bioRxiv. 2023.
38. Bottery MJ, Rhijn N van, Chown H, Rhodes JL, Celia BN, Brewer MT, et al. Elevated mutation rates in the multi-azole resistant Aspergillus fumigatus clade drives rapid evolution of antifungal resistance. bioRxiv. 2023.
39. Sewell TR, Zhang Y, Brackin AP, Shelton JMG, Rhodes J, Fisher MC. Elevated Prevalence of Azole-Resistant Aspergillus fumigatus in Urban versus Rural Environments in the United Kingdom. Antimicrob Agents Chemother. 2019;63(9).
40. Bouchara JP, Declerck P, Cimon B, Planchenault C, de Gentile L, Chabasse D. Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations. Clinical Microbiology and Infection. 1996;2(3):202–8.
41. Jan A, Bashir G, Qadir R, Fomda BA, Sofia, Yaqoob-Hakak A. Modified Germ Tube Test: A Rapid Test for Differentiation of Candida albicans from Candida dubliniensis. International Journal of Contemporary Medical Research. 2018;5(3).
42. Patterson TF, Donnelly JP. New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies. Journal of Fungi. 2019;5(1):9.
Published
Issue
Section
License
Copyright (c) 2024 Natalia Raquel Aguiar Muñoz, Carlos Fernando Yauli Flores (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.